Title: Oligoribonucleotides and Methods of Use Thereof for Treatment of Alopecia, Acute Renal Failure, and Other Diseases
Patent Number: 8,765,699
Filed: Sept. 27, 2005
Lead Inventor: Elena Feinstein, Quark Pharmaceuticals
Title: Oligomeric Compounds and Compositions for Use in Modulation of Small Non-coding RNAs
Patent Number: 8,765,701
Filed: Dec. 30, 2008
Lead Inventor: Frank Bennett, Regulus Therapeutics
Title: Modified Small Interfering RNA Molecules and Methods of Use
Patent Number: 8,765,704
Filed: Dec. 14, 2011
Lead Inventor: Jang Han, Novartis
Title: Oligonucleotides Inhibiting Cellular Migration
Patent Number: 8,765,705
Filed: July 30, 2010
Lead Inventor: Florence Cabon, National Center for Scientific Research
Title: microRNA-104-5p as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
Patent Number: 8,765,707
Filed: April 23, 2012
Lead Inventor: Preethi Gunaratne, Baylor College of Medicine
Title: Methods and Composition involving miRNA and miRNA Inhibitor Molecules
Patent Number: 8,765,709
Filed: Aug. 28, 2013
Lead Inventor: David Brown, Asuragen
Title: RNA Interference-mediating Small RNA Molecules
Patent Number: 8,765,930
Filed: June 4, 2010
Lead Inventor: Thomas Tuschl, Max Planck Institute (Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research, University of Massachusetts)
Title: Double-stranded Oligonucleotide Compound for Down-regulating the Expression of CASP2 Gene
Patent Number: 8,765,931
Filed: Oct. 22, 2009
Lead Inventor: Elena Feinstein, Quark Pharmaceuticals
Title: Compositions and Methods for Inhibiting Expression of XBP-1 Gene
Patent Number: 8,765,932
Filed: Sept. 14, 2012
Lead Inventor: Kevin Fitzgerald, Alnylam Pharmaceuticals
Title: miRNA Target Prediction
Patent Number: 8,768,630
Filed: Feb. 22, 2011
Lead Inventor: Inhan Lee, University of Michigan